Assessment of Alzheimer's disease case-control associations using family-based methods
about
Investigation of 15 of the top candidate genes for late-onset Alzheimer's diseaseGenetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathwaysThe genetics and neuropathology of Alzheimer's diseaseGenetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.ACE variants and association with brain Aβ levels in Alzheimer's diseaseGenotator: a disease-agnostic tool for genetic annotation of disease.Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysisCysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking.No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's DiseaseA multi-center study of ACE and the risk of late-onset Alzheimer's diseaseA delicate balance: Iron metabolism and diseases of the brain.Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.Sortilin receptor 1 predicts longitudinal cognitive change.Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.Angiotensins and Alzheimer's disease: a bench to bedside overviewPharmacogenomics and therapeutic strategies for dementia.Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Neuroimaging, nutrition, and iron-related genes.Evaluating DAPK as a therapeutic target.Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins.Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies.Rs4878104 contributes to Alzheimer's disease risk and regulates DAPK1 gene expression.Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer's disease: a meta-analysis.Sortilin-related VPS10 domain containing receptor 1 and Alzheimer's disease-associated allelic variations preferentially exist in female or type 2 diabetes mellitus patients in southern Han Chinese.The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson's disease.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil.
P2860
Q24628049-5B4DF727-BE5D-4027-BA2F-7B3830576A16Q24629875-DA20B1FF-1DA2-4859-B166-8438DBF7F7C5Q26998097-EBEA19F0-2518-4EE7-80D6-F18F86E9E0E9Q31026808-14806F65-E4D7-48D9-B406-002BBDDD4EAAQ33879307-D201C148-01E1-4DBE-8453-02D1CB9EC530Q34310258-29897EFD-A25C-4952-BE2C-60B78FB7BC03Q34344661-5A3C99CB-D051-4E29-8446-60DBEC3EC38FQ34435017-31A8FFBF-A3CA-4F95-99FC-D68AD6244DB4Q35096287-9C27A021-08F4-4940-999A-31FC9105D37FQ36467254-FC2B69B7-22AE-4707-ADE2-E835D7CD2FB9Q36847601-9A23A267-0927-4CA8-8375-05F4BE5CA71DQ37023585-EFC2BAE3-93B9-433C-A488-90C2CF826E59Q37156193-0755FA67-85A3-4041-AF71-CF584DABBD97Q37304821-7F96D155-3FBC-4D5B-8E74-7E1DC4AD5DAEQ37340530-BC9AE2F5-FECE-4361-8CA2-2F8059EE81B1Q37357625-F1309617-F65D-4A09-BFB6-9CE29C2F03B8Q37578775-470FE1D7-DE90-42FA-8BF0-0FFF9C6E7EC0Q37592250-8FACE7F5-8038-44F0-9E81-4B5B8B965EDDQ38037159-F1220A1A-65A3-4388-9F9C-7F1D570A999DQ38118617-2209B73F-BF3E-4249-96FC-C1FA852864CEQ38168688-2C4FBBEA-57E5-463F-98E4-246550DE8D41Q39142974-2427D91A-98D4-4A76-BBEC-1C5298BC1902Q43120876-600DD821-52AD-4750-9D16-1E169CB53C8EQ44665407-A7A1F330-3B75-4E0B-B9E4-D404F466CABFQ47877929-22EF38E7-09AE-4FD3-8788-DC8A652668EEQ48861506-678C9496-42AC-4872-8A0B-4C367E60FC36Q49024078-A8AB75A1-4E78-48D2-83F9-22469075D093Q50853226-4BA2FD22-5D80-4004-83D5-8740761F7690Q52347539-C039F172-3D79-43CF-9CD0-E4CD67672A5CQ53318750-EC6DD890-2E37-4567-AB65-A2D1BF2C5301
P2860
Assessment of Alzheimer's disease case-control associations using family-based methods
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Assessment of Alzheimer's disease case-control associations using family-based methods
@ast
Assessment of Alzheimer's disease case-control associations using family-based methods
@en
Assessment of Alzheimer's disease case-control associations using family-based methods
@nl
type
label
Assessment of Alzheimer's disease case-control associations using family-based methods
@ast
Assessment of Alzheimer's disease case-control associations using family-based methods
@en
Assessment of Alzheimer's disease case-control associations using family-based methods
@nl
altLabel
Assessment of Alzheimer’s disease case–control associations using family-based methods
@en
prefLabel
Assessment of Alzheimer's disease case-control associations using family-based methods
@ast
Assessment of Alzheimer's disease case-control associations using family-based methods
@en
Assessment of Alzheimer's disease case-control associations using family-based methods
@nl
P2093
P2860
P1433
P1476
Assessment of Alzheimer's disease case-control associations using family-based methods
@en
P2093
Basavaraj Hooli
Brit-Maren M Schjeide
Christoph Lange
Jason DiVito
Kristina Mullin
Lars Bertram
Matthew B McQueen
Meghan F Hogan
Michele Parkinson
P2860
P2888
P356
10.1007/S10048-008-0151-3
P407
P577
2009-02-01T00:00:00Z
P5875
P6179
1000962283